Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Foundation One Genomic Interrogation of Thyroid Cancers in Patients With Metastatic Disease Requiring Systemic Therapy.

The Journal of clinical endocrinology and metabolism - 1 Jul 2020

Iñiguez-Ariza Nicole M, Jasim Sina, Ryder Mabel M, Chintakuntlawar Ashish V, Morris John C, Hilger Crystal R, Menefee Michael E, Smallridge Robert C, Karlin Nina J, Alcaino Constanza, Bible Keith C

Abstract excerpt

CONTEXT: Clinical applications of genomic assessment of thyroid cancers are rapidly evolving. OBJECTIVES, DESIGN, AND SETTING: We studied tumor samples from patients with imminently threatening and rare thyroid cancers to identify genomic alterations that might correlate with outcomes and/or be productively therapeutically targetable. PATIENT CONTEXT: Progressive and metastatic, and/or rare, thyroid cancers were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomics
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Metastasis

Share to Survival Analysis

Share to Thyroid Neoplasms

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 32421817
DOI: 10.1210/clinem/dgaa246
PMCID: PMC7263749

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Foundation One Genomic Interrogation of Thyroid Cancers in Patients With Metastatic Disease Requiring Systemic Therapy.PMID 32421817Read ↗

Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.Semantic proximity Read ↗

Genomic profiling of primary and metastatic thyroid cancers.Semantic proximity Read ↗

High prevalence of potential molecular therapeutic targets in poorly differentiated thyroid carcinomaSemantic proximity Read ↗

Molecular findings in thyroid tumors: Practical diagnostic, prognostic, and therapeutic insights.Semantic proximity Read ↗

Molecular predictive biomarker testing in advanced thyroid cancer - a European consensus.Semantic proximity Read ↗

Genomic alterations in thyroid cancer: biological and clinical insights.Semantic proximity Read ↗

The Genomic Landscape of Thyroid Cancer Tumourigenesis and Implications for Immunotherapy.Semantic proximity Read ↗

Clinical use of Molecular Data in Thyroid Nodules and CancerSemantic proximity Read ↗

Clinically aggressive follicular cell-derived thyroid carcinoma: A comprehensive series with histomolecular characterization and discovery of novel gene fusions.Semantic proximity Read ↗

Update on Molecular Diagnostics in Thyroid Pathology: A ReviewSemantic proximity Read ↗

Review of Genomic Drivers of Thyroid Cancer and Their Clinical Implications.Semantic proximity Read ↗

Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.